Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michela Ranieri

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Molecular Neurobiology|May 10, 2014
Antisense oligonucleotide therapy for the treatment of C9ORF72 ALS/FTD diseasesGiulietta Riboldi, Chiara Zanetta, Michela Ranieri, et al.
Oncotarget|May 5, 2016
Obatoclax kills anaplastic thyroid cancer cells by inducing lysosome neutralization and necrosisDevora Champa, Arturo Orlacchio, Bindi Patel, et al.
Case Reports in Neurology|April 15, 2011
Tyr78Phe Transthyretin Mutation with Predominant Motor Neuropathy as the Initial PresentationGiulietta Riboldi, Roberto Del Bo, Michela Ranieri, et al.
Cancer Research|October 22, 2017
SGK1 Is a Critical Component of an AKT-Independent Pathway Essential for PI3K-Mediated Tumor Development and MaintenanceArturo Orlacchio, Michela Ranieri, Martina Brave, et al.
Functional Neurology|April 20, 2013
Considerations on a mutation in the NOTCH3 gene sparing a cysteine residue: a rare polymorphism rather than a CADASIL variantAnna Bersano, Michela Ranieri, Andrea Ciammola, et al.
ESC Heart Failure|September 11, 2024
Hypocalcaemic cardiomyopathy presenting as heart failure exacerbation due to untreated primary hypoparathyroidismMassimo Mapelli, Alessandro Alberto Nepitella, Stefano Ferdico, et al.
Journal of the Neurological Sciences|December 27, 2011
Optic atrophy plus phenotype due to mutations in the OPA1 gene: two more Italian familiesMichela Ranieri, Roberto Del Bo, Andreina Bordoni, et al.
Current Medicinal Chemistry|February 11, 2016
Vasculogenic and Angiogenic Pathways in Moyamoya DiseaseGloria Bedini, Kinga G Blecharz, Sara Nava, et al.
NPJ Precision Oncology|August 20, 2025
Deep mutational scanning reveals EGFR mutations conferring resistance to the 4th-generation EGFR tyrosine kinase inhibitor BLU-945Yueyang Wang, Yuan Hao, Michela Ranieri, et al.
Neurobiology of Aging|July 28, 2009
No major progranulin genetic variability contribution to disease etiopathogenesis in an ALS Italian cohortRoberto Del Bo, Stefania Corti, Domenico Santoro, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Molecular Neurobiology|May 10, 2014
Antisense oligonucleotide therapy for the treatment of C9ORF72 ALS/FTD diseasesGiulietta Riboldi, Chiara Zanetta, Michela Ranieri, et al.
Oncotarget|May 5, 2016
Obatoclax kills anaplastic thyroid cancer cells by inducing lysosome neutralization and necrosisDevora Champa, Arturo Orlacchio, Bindi Patel, et al.
Case Reports in Neurology|April 15, 2011
Tyr78Phe Transthyretin Mutation with Predominant Motor Neuropathy as the Initial PresentationGiulietta Riboldi, Roberto Del Bo, Michela Ranieri, et al.
Cancer Research|October 22, 2017
SGK1 Is a Critical Component of an AKT-Independent Pathway Essential for PI3K-Mediated Tumor Development and MaintenanceArturo Orlacchio, Michela Ranieri, Martina Brave, et al.
Functional Neurology|April 20, 2013
Considerations on a mutation in the NOTCH3 gene sparing a cysteine residue: a rare polymorphism rather than a CADASIL variantAnna Bersano, Michela Ranieri, Andrea Ciammola, et al.
ESC Heart Failure|September 11, 2024
Hypocalcaemic cardiomyopathy presenting as heart failure exacerbation due to untreated primary hypoparathyroidismMassimo Mapelli, Alessandro Alberto Nepitella, Stefano Ferdico, et al.
Journal of the Neurological Sciences|December 27, 2011
Optic atrophy plus phenotype due to mutations in the OPA1 gene: two more Italian familiesMichela Ranieri, Roberto Del Bo, Andreina Bordoni, et al.
Current Medicinal Chemistry|February 11, 2016
Vasculogenic and Angiogenic Pathways in Moyamoya DiseaseGloria Bedini, Kinga G Blecharz, Sara Nava, et al.
NPJ Precision Oncology|August 20, 2025
Deep mutational scanning reveals EGFR mutations conferring resistance to the 4th-generation EGFR tyrosine kinase inhibitor BLU-945Yueyang Wang, Yuan Hao, Michela Ranieri, et al.
Neurobiology of Aging|July 28, 2009
No major progranulin genetic variability contribution to disease etiopathogenesis in an ALS Italian cohortRoberto Del Bo, Stefania Corti, Domenico Santoro, et al.
Pageof 4